Yahoo Web Search

Search results

    • Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      WFRV 5 Green Bay· 15 hours ago

      ...: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on May 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to...